Doing THIS exercise for five minutes a day can lower blood pressure, experts reveal
A recent study by the ProPASS Consortium reveals that even brief bursts of physical activity, as little as five minutes daily, can significantly lower blood pressure. Replacing sedentary habits with 20-27 minutes of exercise, like uphill walking or stair climbing, can also make a clinically significant difference.
High blood pressure or hypertension is a major risk factor for several serious health conditions, including heart attack, stroke, heart failure, kidney disease, and other complications.
Managing blood pressure is crucial for overall health and well-being. Making certain lifestyle changes can help lower blood pressure, and one of them is regular exercise. A new study has found that even five minutes of physical activity can help manage blood pressure!
According to research led by experts from the ProPASS (Prospective Physical Activity, Sitting and Sleep) Consortium, an international academic collaboration led by the University of Sydney and University College London (UCL), even small amount of physical activity, such as uphill walking or stair-climbing, can lower blood pressure. The findings are published in
Circulation
.
What is hypertension
Hypertension, or a consistently elevated blood pressure level, is one of the biggest causes of premature death globally. This condition affects 1.28 billion adults around the world. High blood pressure happens when the force of the blood pushing against the walls of the blood vessels is too high. It can lead to stroke, heart attack, heart failure, kidney damage, and many other health problems. Due to the lack of any symptoms, it is often described as a 'silent killer'.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
2025 Top Trending local enterprise accounting software [Click Here]
Esseps
Learn More
Undo
Even five minutes of exercise matters
Image Credits: Canva
The researchers found that just five minutes of activity a day potentially reduces blood pressure. Also, replacing sedentary behaviours with 20-27 minutes of exercise per day made a clinically significant difference in blood pressure. These activities could be uphill walking, stair-climbing, running and cycling.
'High blood pressure is one of the biggest health issues globally, but unlike some major causes of cardiovascular mortality, there may be relatively accessible ways to tackle the problem in addition to medication.
The finding that doing as little as five extra minutes of exercise per day could be associated with measurably lower blood pressure readings emphasises how powerful short bouts of higher intensity movement could be for blood pressure management,' joint senior author Professor Emmanuel Stamatakis, the Director of the ProPASS Consortium from the Charles Perkins Centre, said in a statement.
The study
To understand how daily movement affects blood pressure, the researchers analyzed health data from 14,761 volunteers across five countries.
Each participant used a wearable thigh-mounted accelerometer, which can monitor movement and blood pressure levels throughout the day and night.
The researchers split the daily activity into six categories: sleep, sedentary behaviour (such as sitting), slow walking, fast walking, standing, and more vigorous exercise such as running, cycling, or stair climbing.
The team used statistical models to see how swapping one activity for another would affect
blood pressure
.
They found that replacing sedentary behaviour with 20-27 minutes of exercise per day could potentially reduce cardiovascular disease by up to 28% at a population level.
What are the experts saying
'Our findings suggest that, for most people, exercise is key to reducing blood pressure, rather than less strenuous forms of movement such as walking. The good news is that whatever your physical ability, it doesn't take long to have a positive effect on blood pressure.
What's unique about our exercise variable is that it includes all exercise-like activities, from running for a bus or a short cycling errand, many of which can be integrated into daily routines,' first author Dr.
Jo Blodgett from the Division of Surgery and Interventional Science at UCL and the Institute of Sport, Exercise and Health said.
'For those who don't do a lot of exercise, walking still has some positive benefits for blood pressure.
But if you want to change your blood pressure, putting more demand on the cardiovascular system through exercise will have the greatest effect,' Dr. Blodgett added.
Common Blood Pressure Medications Linked to Low Risk of Total Knee Replacement
Professor Mark Hamer, joint senior author of the study and ProPASS Deputy Director from UCL, said: 'Our findings show how powerful research platforms like the ProPASS consortium are for identifying relatively subtle patterns of exercise, sleep, and sedentary behaviour, that have significant clinical and public health importance.'
One step to a healthier you—join Times Health+ Yoga and feel the change
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
US CDC vaccine presentation cites study that does not exist, author says
A review on the use of the preservative thimerosal in vaccines slated to be presented on Thursday to the U.S. Centers for Disease Control and Prevention's outside vaccine committee cites a study that does not exist, the scientist listed as the study's author said. The report, called "Thimerosal as a Vaccine Preservative" published on the CDC website on Tuesday, is to be presented by Lyn Redwood, a former leader of the anti-vaccine group Children's Health Defense. It makes reference to a study called "Low-level neonatal thimerosal exposure: Long-term consequences in the brain," published in the journal Neurotoxicology in 2008, and co-authored by UC Davis Professor Emeritus Robert Berman. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Madrid: Se buscan: 500 personas mayores de 50 años (Haz clic aquí) Experto en Audicion Undo But according to Berman, "it's not making reference to a study I published or carried out." Berman said he co-authored a similarly named study in a different journal - Toxicological Sciences - that came to different conclusions than those suggested by Redwood. Live Events "We did not examine the effects of thimerosal in microglia... I do not endorse this misrepresentation of the research," he said. Reuters is the first to report on the inaccurate citation from Redwood's planned presentation. Later on Tuesday, the CDC uploaded a new version of Redwood's presentation, removing the slide that cited the Berman study. The meeting has become increasingly controversial after Health Secretary Robert F. Kennedy Jr. just weeks ago abruptly fired all previous 17 members of the expert panel and named eight new members, half of whom have advocated against vaccines. Kennedy, a long-time anti-vaccine activist, founded the Children's Health Defense. Both Republican U.S. Senator Bill Cassidy of Louisiana and Democratic U.S. Senator Patty Murray of Washington said the June 25 and 26 meeting should be postponed. The summary of the presentation suggested that there are enough thimerosal-free flu vaccines and that all pregnant women, infants and children should receive only those shots. It was not clear if the new advisory panel would be asked to vote on such a move. Redwood's presentation was in contrast to a separate report posted by CDC staff on the CDC website on Tuesday that says evidence does not support a link between thimerosal-containing vaccines and autism or other neurodevelopmental disorders. Kennedy has long pushed a link between vaccines and autism contrary to scientific evidence. Redwood could not be immediately reached for comment. An HHS spokesman said the study being referenced was the Toxicological Sciences study Berman said was being misrepresented. The CDC's briefing material reviewed some studies on neurodevelopmental outcomes and vaccines that contain thimerosal, which has long been used in the U.S. in multi-dose vials of medicines and vaccines to prevent germs from growing in them. According to the CDC report, 96% of all influenza vaccines in the U.S. were thimerosal free during the 2024-25 flu season. It also added that the number of pregnant women receiving a thimerosal-containing flu vaccine has decreased over time, with only 0.3% of doses given in 2024 containing thimerosal. Kennedy wrote a book in 2014 claiming that thimerosal, a mercury-based preservative, causes brain damage. On Monday, Cassidy, who heads the U.S. Senate Committee on Health, Education, Labor and Pensions, called for the meeting to be delayed, saying it should not take place with a relatively small panel and without a CDC director in place. Murray, a senior member and former chair of the HELP Committee, has also called for the fired panel members to be reinstated or the meeting be delayed until new members are appropriately vetted.
Time of India
2 hours ago
- Time of India
Bharat Biotech, GSK to halve price of malaria vaccine by 2028
Drugmakers Bharat Biotech and GSK will cut the price of their malaria vaccine to $5 per dose by 2028, more than halving its current cost, they said on Wednesday. The vaccine, Mosquirix or RTS,S, was developed by GSK and the non-profit PATH, and was the first malaria vaccine to get approval from the World Health Organization in 2022. GSK is working on a technology transfer to Bharat, and will continue to supply the adjuvant part of the vaccine to Bharat when the Indian drugmaker fully takes over production of the shot by 2028. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Villa For Sale in Dubai Might Surprise You Villas in Dubai | Search ads Learn More Undo A phased reduction in price for the vaccine will begin immediately, GSK said in a statement with Bharat, reaching the target price of $5 by 2028. The price cut was "driven by process improvements, expanded production capacity, cost-effective manufacturing, and minimal profit margins," the statement read. Live Events Malaria kills more than 500,000 people annually, mainly children aged five and under in sub-Saharan Africa, according to WHO estimates. Cases and deaths fell significantly between 2000 and 2015, but progress has since stalled and even reversed, with a particular jump in mortality during the COVID-19 pandemic. Many experts have expressed hope that vaccines can help turn the tide in the fight against the mosquito-borne disease. But price has been an issue, particularly when compared to other tools to prevent malaria like bed nets. GSK has previously said it was committed to supplying up to 18 million vaccine doses between 2023 and the end of this year. The company plans to supply 15 million doses annually from 2026-2028, according to a spokesperson. Wednesday's announcement comes as Gavi - a global vaccine group that helps buy childhood vaccines in the world's poorest countries - holds an event in Brussels to raise funding for its work over the next five years, as governments pull back from international aid. GSK and Bharat said the price reduction showed their commitment to Gavi, which has been funding some of the roll-out of the malaria vaccine. Twelve African countries are set to introduce the vaccine in their routine immunisation programmes by the end of this year with Gavi's support. The other approved malaria vaccine, developed by the University of Oxford and the Serum Institute of India, is priced at under $4 a dose.
Time of India
2 hours ago
- Time of India
Fatty liver in fit people: Can you be thin and still have NAFLD? (key symptoms inside)
Despite appearances, lean individuals can develop non-alcoholic fatty liver disease (NAFLD), now known as metabolic dysfunction–associated steatotic liver disease (MASLD). This 'thin outside, fat inside' condition is often overlooked, with visceral fat, insulin resistance, and genetics playing key roles. Symptoms are subtle, including fatigue and abdominal discomfort. Appearances are often deceptive. There's a reason why proverbs like 'All that glitters is not gold', 'Don't judge a book by its cover' have stayed relevant throughout the ages. It is to reiterate the fact that oftentimes, what meets the eyes isn't the truth – but that truth lies deep within. In the periphery of health, too, you can look absolutely healthy while worrisome diseases might be festering inside. Fatty liver is one of those diseases. One can be lean and have a visibly fit physique and still have fatty liver – also known as – non‑alcoholic fatty liver disease (NAFLD). In fact, what's often overlooked is the growing recognition of lean NAFLD – a condition where apparently healthy individuals develop fat accumulation in the liver. Let's unpack. What is NAFLD – and what about "lean" cases? NAFLD, now often referred to as metabolic dysfunction–associated steatotic liver disease (MASLD), is defined by excess fat in liver tissue without alcohol as the cause. Initially, it was linked closely to obesity and metabolic syndrome – conditions with high BMI, insulin resistance, and dyslipidemia. Yet over 10–20% of individuals with NAFLD are lean – with normal BMI (<25 kg/m² for Caucasians, <23 kg/m² for Asians). by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Wien: Hansaton sucht 250 Testhörer vor 1972 geboren Hansaton Jetzt anmelden Undo This 'thin outside, fat inside' phenotype is increasingly recognized in clinical studies: lean-NAFLD prevalence is reported at 5–26% worldwide, with even higher rates (~25%) in some Asian regions. Through thick and thin: Why can lean people get NAFLD? Lean or athletic people can and do develop NAFLD. Here's why. Visceral fat and insulin resistance: Thin individuals may still carry a high proportion of visceral fat – deep fat around internal organs, which is more harmful than subcutaneous fat. Even with normal glucose and lipid levels, they can exhibit insulin resistance – a core driver of fat build‑up in the liver. Sarcopenia and fat repartitioning: According to research , many lean NAFLD patients have lower muscle mass (sarcopenia) alongside more visceral fat. This imbalance disrupts metabolism and encourages liver steatosis. Genetics and environment: Variants in genes like PNPLA3 and TM6SF2 increase NAFLD risk irrespective of weight. Diets high in fructose, cholesterol, low activity levels, pollutant exposure, and microbiome shifts also contribute. What symptoms to watch out for? Unfortunately, many lean NAFLD cases are asymptomatic and discovered incidentally through imaging or elevated liver enzymes. When symptoms occur, they're often subtle. They include fatigue and low energy, mild discomfort or dull pain in the upper right abdomen (under the ribs), or abnormal liver enzymes in routine bloodwork: ALT/AST or GGT. Some physical clues like dark skin patches around the neck or armpits, or cholesterol deposits on eyelids (xanthelasmas) – although they are rare. Red flag symptoms indicating more progressed forms (steatohepatitis or early fibrosis/MASH) include persistent abdominal pain, worsening fatigue, and possible inflammation signs (though these are often silent). How does the disease severity vary? Despite a normal exterior, lean NAFLD can be just as serious. Liver inflammation and fibrosis can be comparable to those in obese counterparts. In some cases, lean individuals show higher liver enzyme levels, possibly because lean patients are diagnosed later. They often face an increased risk of type 2 diabetes, cardiovascular disease, and even higher all‑cause mortality compared to healthy individuals. What should the lean and apparently healthy individuals do? Be vigilant: If you're fit but have symptoms like fatigue, mild abdominal discomfort, or abnormal liver panels, ask your doctor about NAFLD. Standard BMI-based assessments may miss lean cases. Diagnostic tools: Consult a professional healthcare provider. They might be using blood markers and liver enzymes, ultrasound, or elastography (FibroScan) for an accurate diagnosis. Non-invasive panels or calculators might come in handy to determine liver fat or fibrosis risk. Lifestyle fix: Although weight loss may not apply, metabolic improvements are vital. Sign up for a Mediterranean-style diet, rich in plant-based fats and lean protein, low in sugar, and refined carbs. Regular exercise is a must, even for lean individuals – who can benefit from cardio and strength will help in reducing visceral fat. Be conscious of your body composition. Build muscle to combat sarcopenia and reduce visceral adiposity. Control metabolic factors, keep blood sugar, lipids, and blood pressure in check. And finally, make regular check-ups a habit to track liver fat and make an early diagnosis. Fatty liver disease adversely affects brain health: Study One step to a healthier you—join Times Health+ Yoga and feel the change
